Hydrallazine-induced Cutaneous Vasculitis

Overview

Journal Br Med J

Specialty General Medicine

Date 1980 Jan 19

PMID 7357301

Citations 14

Authors

R M Bernstein

J Webster

Affiliations

Soon will be listed here.

Citing Articles

Focal Alveolar Hemorrhage Secondary to Hydralazine-Associated Antineutrophilic Cytoplasmic Antibody Vasculitis.

Martinez Manzano J, Jarrett S, Lo K, Sen M, Tan I Cureus. 2023; 15(7):e42031.

PMID: 37465085 PMC: 10351746. DOI: 10.7759/cureus.42031.

Hydralazine-induced vasculitis presenting with ocular manifestations.

Hawn V, Vo T, Flomenbaum D, Gibralter R Am J Ophthalmol Case Rep. 2022; 26:101515.

PMID: 35464686 PMC: 9020102. DOI: 10.1016/j.ajoc.2022.101515.

Severe cutaneous presentation of hydralazine-induced ANCA vasculitis without renal or pulmonary involvement, complicated by DIC.

Huo M, Avelino A, Singh G BMJ Case Rep. 2021; 14(5).

PMID: 33975832 PMC: 8118062. DOI: 10.1136/bcr-2020-238609.

Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review.

Doughem K, Battisha A, Sheikh O, Konduru L, Madoukh B, Al-Sadawi M Curr Cardiol Rev. 2020; 17(2):182-187.

PMID: 32418528 PMC: 8226194. DOI: 10.2174/1573403X16666200518092814.

A simultaneous presentation of drug-induced lupus with drug-induced ANCA vasculitis secondary to hydralazine use in a patient with sarcoidosis.

Espinosa M, Ding B, Choi K, Cohen D, Marcelli M, Ifoeze O Proc (Bayl Univ Med Cent). 2019; 32(2):231-234.

PMID: 31191136 PMC: 6541081. DOI: 10.1080/08998280.2019.1570422.

References

PERRY Jr H . Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis. Am J Med. 1973; 54(1):58-72. DOI: 10.1016/0002-9343(73)90084-3. View

Strandberg I, Boman G, Hassler L, Sjoqvist F . Acetylator phenotype in patients with hydralazine-induced lupoid syndrome. Acta Med Scand. 1976; 200(5):367-71. DOI: 10.1111/j.0954-6820.1976.tb08248.x. View